Class information for:
Level 1: BAFF//APRIL//BLYS

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
4988 1622 46.0 92%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
914 10549 CD40//BAFF//CD40 LIGAND

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 BAFF Author keyword 198 65% 12% 187
2 APRIL Author keyword 144 76% 6% 101
3 BLYS Author keyword 83 73% 4% 63
4 BELIMUMAB Author keyword 57 65% 3% 54
5 A PROLIFERATION INDUCING LIGAND Author keyword 50 88% 1% 23
6 BAFF R Author keyword 39 74% 2% 29
7 B LYMPHOCYTE STIMULATOR Author keyword 36 77% 1% 24
8 TACI Author keyword 34 61% 2% 36
9 ATACICEPT Author keyword 33 83% 1% 19
10 B CELL ACTIVATING FACTOR Author keyword 28 50% 3% 41

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class		 LCSH search Wikipedia search
1 BAFF 198 65% 12% 187 Search BAFF Search BAFF
2 APRIL 144 76% 6% 101 Search APRIL Search APRIL
3 BLYS 83 73% 4% 63 Search BLYS Search BLYS
4 BELIMUMAB 57 65% 3% 54 Search BELIMUMAB Search BELIMUMAB
5 A PROLIFERATION INDUCING LIGAND 50 88% 1% 23 Search A+PROLIFERATION+INDUCING+LIGAND Search A+PROLIFERATION+INDUCING+LIGAND
6 BAFF R 39 74% 2% 29 Search BAFF+R Search BAFF+R
7 B LYMPHOCYTE STIMULATOR 36 77% 1% 24 Search B+LYMPHOCYTE+STIMULATOR Search B+LYMPHOCYTE+STIMULATOR
8 TACI 34 61% 2% 36 Search TACI Search TACI
9 ATACICEPT 33 83% 1% 19 Search ATACICEPT Search ATACICEPT
10 B CELL ACTIVATING FACTOR 28 50% 3% 41 Search B+CELL+ACTIVATING+FACTOR Search B+CELL+ACTIVATING+FACTOR

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 NECROSIS FACTOR FAMILY 642 76% 28% 452
2 B LYMPHOCYTE STIMULATOR 323 71% 16% 263
3 LYMPHOCYTE STIMULATOR 307 80% 12% 191
4 BLYS 278 82% 10% 164
5 BAFF 175 50% 16% 252
6 BAFF R 163 76% 7% 113
7 TNF FAMILY 162 60% 11% 175
8 APRIL 129 49% 12% 195
9 TACI 124 62% 8% 128
10 BLYS RECEPTOR 107 97% 2% 31

Journals

Reviews


Title Publ. year Cit. Active references % act. ref.
to same field
Cracking the BAFF code 2009 273 106 64%
Biologicals for the treatment of systemic lupus erythematosus: current status and emerging therapies 2015 3 39 51%
The BAFF/APRIL system: Emerging functions beyond B cell biology and autoimmunity 2013 41 141 79%
The BAFF/APRIL system in SLE pathogenesis 2014 16 100 71%
B cells and the BAFF/APRIL axis: fast-forward on autoimmunity and signaling 2007 145 103 87%
Efficacy of rituximab in 164 patients with biopsy-proven lupus nephritis: Pooled data from European cohorts 2012 51 39 62%
B-cell depletion in SLE: clinical and trial experience with rituximab and ocrelizumab and implications for study design 2013 29 68 68%
An APRIL to remember: novel TNF ligands as therapeutic targets 2006 186 98 88%
The efficacy of novel B cell biologics as the future of SLE treatment: A review 2014 10 54 67%
Efficacy and safety of rituximab in the treatment of non-renal systemic lupus erythematosus: A systematic review 2014 6 31 94%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 JIANGSU PROV MOL MED BIOTECHNOL 11 23% 2.6% 42
2 CHARITE 12 5 63% 0.3% 5
3 CHARITE 14 4 75% 0.2% 3
4 LOUIS JEANTET 4 75% 0.2% 3
5 MED RHEUMATOL CLIN IMMUNOL 2 4 75% 0.2% 3
6 REFERENCE LUPUS SYNDROME ANTICORPS ANT 3 60% 0.2% 3
7 ARTHRITIS INFLAMMAT 3 35% 0.4% 6
8 ANTIBODY DISCOVERY DEV 2 67% 0.1% 2
9 ARTHRITIS ASTHMA PROGRAM 2 67% 0.1% 2
10 CHARITE 12 14 2 67% 0.1% 2

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000120805 REGULATORY B CELLS//CD40 ACTIVATED B CELLS//REGULATORY B CELL
2 0.0000111991 MEMORY B CELL//GERMINAL CENTER//B CELL MIGRATION
3 0.0000106855 RECEPTOR EDITING//SURROGATE LIGHT CHAIN//PRE B CELL RECEPTOR
4 0.0000095958 CD20//OFATUMUMAB//OBINUTUZUMAB
5 0.0000092197 LUPUS NEPHRITIS//SYSTEMIC LUPUS ERYTHEMATOSUS//LUPUS
6 0.0000086826 IL10 GENE//INTERLEUKIN 10 PROMOTER//RHEUMATOL INTERNAL MED 3
7 0.0000082510 UNC93B1//MARY KIRKLAND LUPUS//TLR7
8 0.0000065139 FN14//TWEAK//STWEAK
9 0.0000054361 ANTI TNF ALPHA THERAPIES//GENHOTEL RECH EUROPEEN POLYARTHRITE RHUMATOID//PATHOL RHEUMATOL
10 0.0000050597 SJOGRENS SYNDROME//PRIMARY SJOGRENS SYNDROME//BROEGELMANN